Anthos Therapeutics

Edit info

Founded: 2018

Location: Cambridge, MA

Employee range: 11 - 50

Clinical stage: Clin3 (fast track)

Therapy area: Cancer associated thrombosis (FT)

Drug types: HEM, CVV

Lead product: Abelacimab

Funding: $250M Feb 2019

Investors: Blackstone, Novartis

anthostherapeutics.com

linkedin.com

job board

Drug notes:

Also Clin3 (fast track) stroke and embolism in atrial fibrillation, Clin2 venous thromboembolism

About:

Anthos is a clinical stage biopharmaceutical company based in Cambridge, MA that was launched in 2019 by Blackstone Life Sciences. They are focused on developing and validating therapeutics for cardiovascular and metabolic diseases. Anthos hopes to significantly reduce the prevalence of stroke and heart attack by offering an alternative to traditional anticoagulants, which have limited use due to their increased potential for bleeding events.

Jobs:

Main

Contact: recruit@workinbiotech.com